Study connects late-life psychosis to abnormal tau protein buildup
Hallucinations and delusions that appear for the first time in midlife or later are often treated as psychiatric…
Rutgers study maps distinct patterns of brain connection loss in schizophrenia
Research involving a Rutgers professor sheds new light on the biological basis of schizophrenia by directly measuring synaptic…
Study identifies PPP2R5C blood marker that may detect Alzheimer’s disease earlier
Researchers report that declining PPP2R5C levels in blood may signal early Alzheimer’s pathology, offering new insight into tau…
Simple blood test maps hidden Alzheimer’s disease changes
A large community study shows that Alzheimer’s-related brain changes are far more widespread with age than symptoms alone…
Blood-based biomarkers and the new landscape of Alzheimer’s research
For much of the past century, Alzheimer’s disease has been one of medicine’s most daunting frontiers – biologically…
Midlife blood test may reveal Alzheimer’s disease risk in advance
A simple blood test for platelet activity at middle age could one day help identify people at risk…
New WashU center aims to transform disease diagnosis through AI imaging
Mallinckrodt Institute of Radiology (MIR) at Washington University School of Medicine in St. Louis is establishing a new…
Digital test plus blood biomarker boosts accuracy of Alzheimer’s diagnosis in primary care
By confirming cognitive impairment before ordering amyloid blood tests, this two-step approach cuts false positives, streamlines referrals, and…
Blood and brain biomarkers transform how doctors confirm Alzheimer’s disease
By integrating clinical assessment with cutting-edge biomarkers, researchers chart a practical pathway to faster and fairer Alzheimer’s diagnosis,…
Two-step blood and scan strategy delivers near-perfect accuracy for early Alzheimer signs
A simple blood test for p-tau217, when combined with confirmatory brain scans or CSF analysis, could transform early…